alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EX-10.2



 Exhibit 10.2 

ASSIGNMENT AND ASSUMPTION OF PURCHASE AGREEMENT 

This ASSIGNMENT AND ASSUMPTION OF PURCHASE AGREEMENT (“Assignment”) is made as of July 30, 2017 between ZymoGenetics,
Inc., a Washington corporation (“Assignor”), and Seattle Genetics, Inc., a Delaware corporation (“Assignee”), and is entered into with reference to the following facts: 

1. Assignor is the Buyer under that certain Purchase Agreement dated as of June 16, 2017, by and between Assignor and BMR-3450 Monte Villa
Parkway LLC, a Delaware limited liability company, as Seller (the “Purchase Agreement”), with respect to all of the real property, appurtenances, improvements, personal property and intangible property included in the definition of
“Property” therein located in Bothell, Washington, and commonly known as Monte Villa Parkway Research Center, Bothell, Washington. 

2. Assignor has the right to assign all of its right, title and interest under the Purchase Agreement to Assignee as provided herein. 

3. Assignor desires to assign all of its right, title and interest as Buyer under the Purchase Agreement to Assignee, and Assignee desires to
assume all of Assignor’s right, title and interest as Buyer under the Purchase Agreement. 
 NOW THEREFORE, in consideration of
the mutual covenants contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 

1. Assignor hereby assigns to Assignee all of Assignor’s right, title and interest as Buyer under the Purchase Agreement, and Assignee
accepts the assignment and assumes and agrees to perform, all the obligations of Assignor as Buyer under the Purchase Agreement. 
 2. This
Assignment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns. The parties shall execute and deliver or cause to be executed and delivered such further instruments and documents and to
take such further action as may be reasonably necessary to effect or carry out the provisions contemplated by this Assignment. 
 3.
Assignor represents and warrants to Assignee that, to the best of Assignor’s knowledge, (i) the Purchase Agreement is in full force and effect, (ii) Buyer has performed all Buyer obligations under the Purchase Agreement which as of
the date hereof have been required to be performed, and (iii) no event or condition has occurred, or is occurring, that is an event of default under the Purchase Agreement. 

4. This Assignment is made without any representation or warranty, express or implied, except for those representations and warranties, if
any, expressly set forth herein. 
 5. This Assignment may be signed in one or more counterparts and together the counterparts shall
constitute an original assignment. 
 Signature page follows. 








									
	ASSIGNOR:	 		 	ASSIGNEE:
			
	ZYMOGENETICS, INC.,	 		 	SEATTLE GENETICS, INC.,
	a Washington corporation	 		 	a Delaware corporation
					
	By:	 	/s/ Denis Butkovic	 		 	By:	 	/s/ Clay B. Siegall
	Name:	 	Denis Butkovic	 		 	Name:	 	Clay B. Siegall, Ph.D.
	Title:	 	Authorized Signatory	 		 	Title:	 	President and CEO
# C_2022414EN.01004101.xml

| 28.10.2022 | EN | Official Journal of the European Union | C 414/41 |
| --- | --- | --- | --- |

28.10.2022

EN

Official Journal of the European Union

C 414/41

---

Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1)
  )

(Text with EEA relevance)

(2022/C 414/04)

Decision granting an authorisation

| Reference of the decision (2) | Date of decision | Substance name | Holder(s) of the authorisation | Authorisation number | Authorised use | Date of expiry of review period | Reasons for the decision |
| --- | --- | --- | --- | --- | --- | --- | --- |
| C(2022) 7397 | 21 October 2022 | 4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated
  (4-tert-OPnEO)
  EC No: -, CAS No:- | Teva Baltics UAB, Moletu road 5, 08409 Vilnius, Lithuania | REACH/22/36/0 | As a non-ionic surfactant for microbial cells disruption and washing of inclusion bodies in biological drug substance manufacturing process | 4 January 2033 | In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the uses of the substance and there are no suitable alternative substances or technologies. |

Reference of the decision (2)

Date of decision

Substance name

Holder(s) of the authorisation

Authorisation number

Authorised use

Date of expiry of review period

Reasons for the decision

C(2022) 7397

21 October 2022

4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated

(4-tert-OPnEO)

EC No: -, CAS No:-

Teva Baltics UAB, Moletu road 5, 08409 Vilnius, Lithuania

REACH/22/36/0

As a non-ionic surfactant for microbial cells disruption and washing of inclusion bodies in biological drug substance manufacturing process

4 January 2033

In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the uses of the substance and there are no suitable alternative substances or technologies.

---

(1)  OJ L 396, 30.12.2006, p. 1.

(2)  The decision is available on the European Commission website at: Authorisation (europa.eu).

---
**EXHIBIT 12.1**PACIFIC ENTERPRISES**COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES**(Dollars in millions)
2001
2002
2003
2004
2005
Fixed Charges:
Interest 
 $             88 
 $             63 
 $             54 
 $             47 
 $             55 
Interest portion of annual rentals
3 
                  2 
                  2 
                  2 
                  3 
Preferred dividends of subsidiaries (1)
2 
2 
2 
                  2 
                  2 
Total fixed charges for purpose of ratio
 $             93 
 $             67 
 $             58 
 $             51 
 $             60 
Earnings:
Pretax income from continuing operations
 $            377 
 $            383 
 $            361 
 $            390 
 $            324 
Total fixed charges (from above)
93 
67 
58 
51 
60 
Total earnings for purpose of ratio
 $            470 
 $            450 
 $            419 
 $            441 
 $            384 
Ratio of earnings to fixed charges
5.05 
6.72 
7.22 
8.65 
6.40 
(1) In computing this ratio, "Preferred dividends of subsidiaries" represents the before-tax earnings necessary to pay such dividends, 
computed at the effective tax rates for the applicable periods.********
# Official Journal L 57/2013

| | ISSN 1977-0677
  doi:10.3000/19770677.L_2013.057.eng |
| --- | --- |
| Official Journal
  of the European Union | L 57 |
| | |
| English edition | Legislation | Volume 5628 February 2013 |

ISSN 1977-0677

doi:10.3000/19770677.L_2013.057.eng

Official Journal

of the European Union

L 57

English edition

Legislation

Volume 5628 February 2013

---

| Contents | | I   Legislative acts | page |
| --- | --- | --- | --- |
| | | BUDGETS |
| | | 2013/83/EU, Euratom |
| | * | Definitive adoption of amending budget No 6 of the European Union for the financial year 2012 | 1 |

Contents

I   Legislative acts

page

BUDGETS

2013/83/EU, Euratom

*

Definitive adoption of amending budget No 6 of the European Union for the financial year 2012

1

| All amounts in this budget document are expressed in euro unless otherwise indicated.


  Any revenue provided for in Article 18(1) of the Financial Regulation, entered in Titles 5 and 6 of the statement of revenue, may lead to additional appropriations being entered on the headings which bore the initial expenditure giving rise to the corresponding revenue.


  Figures for outturn refer to all authorised appropriations, including budget appropriations, additional appropriations and earmarked revenue. |
| --- |

All amounts in this budget document are expressed in euro unless otherwise indicated.

All amounts in this budget document are expressed in euro unless otherwise indicated.

Any revenue provided for in Article 18(1) of the Financial Regulation, entered in Titles 5 and 6 of the statement of revenue, may lead to additional appropriations being entered on the headings which bore the initial expenditure giving rise to the corresponding revenue.

Any revenue provided for in Article 18(1) of the Financial Regulation, entered in Titles 5 and 6 of the statement of revenue, may lead to additional appropriations being entered on the headings which bore the initial expenditure giving rise to the corresponding revenue.

Figures for outturn refer to all authorised appropriations, including budget appropriations, additional appropriations and earmarked revenue.

Figures for outturn refer to all authorised appropriations, including budget appropriations, additional appropriations and earmarked revenue.

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.
<PAGE>
 
                                  EXHIBIT 10.8
           SUMMARY OF COMPANY'S 1998 MANAGEMENT INCENTIVE PLAN (MIP)
                             PITT-DES MOINES, INC.
                                        

Under the terms of the MIP, a minimum rate of return of (threshold) on
stockholders' equity must be achieved before bonuses can be awarded.  The
threshold for executive officers was established at the after-tax cost of
capital on the assumption that returns in excess of the threshold would lead to
increases in stockholder value.  Once this criteria is met, the total amount of
bonus available for distribution to eligible executive officers, including the
Company's Chief Executive Officer ("CEO") under the MIP is based on a percentage
in excess of the minimum return on stockholders' equity.  Individual bonus
amounts paid to the Company's executive officers for services rendered in 1998,
including the CEO, were based on a pre-determined percentage limitation on each
individual's base salary (in no case does the applicable limit exceed 100% of
base salary) and the percentage of the overall MIP target achieved.  These pre-
determined percentages were established by the Compensation Committee.

Under the terms of the MIP, the Company's eligible executive officers were
entitled to receive and were awarded bonuses under the MIP for the year ended
December 31, 1998.
# Official Journal C 112/2012

| | ISSN 1977-091X
  doi:10.3000/1977091X.C_2012.112.eng |
| --- | --- |
| Official Journal
  of the European Union | C 112 |
| | |
| English edition | Information and Notices | Volume 5518 April 2012 |

ISSN 1977-091X

doi:10.3000/1977091X.C_2012.112.eng

Official Journal

of the European Union

C 112

English edition

Information and Notices

Volume 5518 April 2012

---

| Notice No | Contents | page |
| --- | --- | --- |
| | III   Preparatory acts |
| | Court of Auditors |
| 2012/C 112/01 | Opinion No 2/2012 (pursuant to the second subparagraph of Article 287(4) and Article 311 and Article 322(2) of the Treaty on the Functioning of the European Union in conjunction with Article 106a of the Treaty establishing the European Atomic Energy Community) on an amended proposal for a Council Decision on the system of own resources of the European Union — COM(2011) 739, on an amended proposal for a Council Regulation laying down implementing measures for the system of own resources of the European Union — COM(2011) 740, on an amended proposal for a Council Regulation on the methods and procedure for making available the traditional and GNI-based own resources and on the measures to meet cash requirements — COM(2011) 742, on a proposal for a Council Regulation on the methods and procedure for making available the own resource based on the value added tax — COM(2011) 737, on a proposal for a Council Regulation on the methods and procedure for making available the own resource based on the financial transaction tax — COM(2011) 738 | 1 |

Notice No

Contents

page

III   Preparatory acts

Court of Auditors

2012/C 112/01

Opinion No 2/2012 (pursuant to the second subparagraph of Article 287(4) and Article 311 and Article 322(2) of the Treaty on the Functioning of the European Union in conjunction with Article 106a of the Treaty establishing the European Atomic Energy Community) on an amended proposal for a Council Decision on the system of own resources of the European Union — COM(2011) 739, on an amended proposal for a Council Regulation laying down implementing measures for the system of own resources of the European Union — COM(2011) 740, on an amended proposal for a Council Regulation on the methods and procedure for making available the traditional and GNI-based own resources and on the measures to meet cash requirements — COM(2011) 742, on a proposal for a Council Regulation on the methods and procedure for making available the own resource based on the value added tax — COM(2011) 737, on a proposal for a Council Regulation on the methods and procedure for making available the own resource based on the financial transaction tax — COM(2011) 738

(pursuant to the second subparagraph of Article 287(4) and Article 311 and Article 322(2) of the Treaty on the Functioning of the European Union in conjunction with Article 106a of the Treaty establishing the European Atomic Energy Community)

1

---

| EN | |
| --- | --- |

EN
**Exhibit 12.1****COLONIAL REALTY LIMITED PARTNERSHIP****Ratio of Earnings to Fixed Charges**                   **For the three-month period** **For the nine-month period**  **ended September 30,** **ended September 30,***(all dollar amounts in thousands)* **2007** **2006** **2007** **2006**     **Earnings:**                Pre-tax income (loss) before adjustment for minority interest inconsolidated subsidiaries or income, loss from equity investees,extraordinary gain or loss, or gains on sale of properties $(45,353) $(7,161) $(75,149) $(11,844)Amortization of interest capitalized  600   600   1,800   1,800 Interest capitalized  (6,599)  (4,714)  (20,191)  (11,404)Distributed income of equity investees  3,236   2,553   8,489   7,345 Fixed charges  25,757   38,081   97,993   111,470                       Total earnings $(22,359) $29,359  $12,942  $97,367                       **Fixed Charges:**                Interest expense $17,843  $31,937  $72,326  $95,685 Capitalized interest  6,599   4,714   20,191   11,404 Debt costs amortization  1,315   1,430   5,476   4,381                       Total Fixed Charges $25,757  $38,081  $97,993  $111,470                       **Ratio of Earnings to Fixed Charges**  (a)  (a)  (a)  (a)      a) *For the three months ended September 30, 2007 and2006, the aggregate amount of fixed charges exceededour earnings by approximately $48.1 million and $8.7million, respectively, which is the amount ofadditional earnings that would have been required toachieve a ratio of earnings to fixed charges of 1.0xfor such period. For the nine months ended September30, 2007 and 2006, the aggregate amount of fixedcharges exceeded our earnings by approximately $85.0million and $14.1 million, respectively, which is theamount of additional earnings that would have beenrequired to achieve a ratio of earnings to fixedcharges of 1.0x for such period. The deficiency ofthe ratio of earnings to fixed charges for allperiods presented is primarily due to the $43.3million non-cash impairment charge related to CRLP’sfor-sale residential business and classification ofoperations for assets held for sale and sold asdiscontinued operations. The deficiency of the ratio of earnings tofixed charges for the nine months ended September 30, 2007 is alsodue to $11.0 million of transaction costs associated with theoffice and retail joint venture transactions which closed in June 2007.*The ratios of earnings to fixed charges were computed by dividing earnings byfixed charges. For this purpose, earnings consist of pre-tax income fromcontinuing operations before adjustment for minority interest in consolidatedsubsidiaries or income or loss from equity investees, gains on sale ofproperties, distributed income of equity investees, fixed charges andamortization of capitalized interest excluding interest costs capitalized.Fixed charges consist of interest expense (including interest costscapitalized) and amortization of debt issuance costs.
43
#### ALLEN v. STATE.

No. 20302.

Court of Criminal Appeals of Texas.

March 22, 1939.

Rehearing Denied May 17, 1939.

M. E. Gates, of Huntsville, for appellant.

Lloyd W. Davidson, State’s Atty., of Austin, for the State.

KRUEGER, Judge.

Conviction is for theft of hog; punishment is assessed at confinement in the state penitentiary for a term of two years.

The record is before us without a statement of facts or bills of exceptions. The indictment is sufficient to charge the offense, and procedural matters appear to be in due order.

The judgment is affirmed.

PER CURIAM.

The foregoing opinion of the Commission of Appeals has been examined by the Judges of the Court of Criminal Appeals and approved by the Court.
EX-4.5



 Exhibit 4.5 

CONSENT OF STIKEMAN ELLIOTT LLP 
 Dated:
October 30, 2017 
 We hereby consent to the references to our firm name and opinion under the headings “Eligibility for Investments” and
“Certain Canadian Federal Income Tax Considerations” in each case in the Information Circular that forms a part of the Registration Statement on Form F-8 dated October 30, 2017 filed by METRO Inc. under the Securities Act of 1933, as
amended (the “Act”). In giving this consent, we do not thereby admit that we come within the category of persons whose consent is required by the Act or the rules thereunder. 

 

			
	Yours truly,
	
	 By: /s/ STIKEMAN ELLIOTT LLP

	 STIKEMAN ELLIOTT LLP
Exhibit 32.2








Chief Financial Officer’s Certification required under Section 906 of Sarbanes-Oxley Act of 2002





In connection with the quarterly report of TIB Financial Corp. (the “Company”) on Form 10-Q for the period ended June 30, 2011, as filed with the Securities and Exchange Commission (the “Report”), I, Christopher G. Marshall, Chief Financial Officer of the Company, certify pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that this Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that, to my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.








Date:           August 15, 2011
/s/ Christopher G. MarshallChristopher G. Marshall

Chief Financial Officer











A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to TIB Financial Corp. and will be retained by TIB Financial Corp. and furnished to the Securities and Exchange Commission or its staff upon request.
EXHIBIT 23-1


                       CONSENT OF INDEPENDENT ACCOUNTANTS


         We hereby consent to the incorporation by reference in the Prospectuses
constituting  part of the Registration  Statements on Form S-3 (Nos.  333-23659,
33-53435, 333-23653,  333-04813, 333-53501, and 2-76135) and in the Registration
Statements  on  Form  S-8  (Nos.  333-23981,   333-23645,  333-12827,  33-62892,
333-23655,  and  33-43838) of our report dated  February 17, 1999,  appearing on
page 33 of  Pennsylvania  Enterprises,  Inc's Annual Report on Form 10-K for the
two years in the period ended December 31, 1998 and 1997.


PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
March 1, 1999
Exhibit 32.1
 
 
 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 In connection with the Quarterly Report of DC Brands International, Inc., a Colorado corporation (the “Company”), on Form 10-Q for the period ended June 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stephen Horgan, Chief Executive Officer of the Company, certify, pursuant to Section 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
 
 (1)
The Report fully complies with the requirements of Section 13(a) and 15(d) of the Securities Exchange Act of 1934; and
 
 (2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 /s/ Stephen Horgan
 Chief Executive Officer
 (Principal Executive Officer)
 August 20, 2012
[LOGO]

Somekh Chaikin
Tel-Aviv, February 8, 1998

Auditor's Report to the Shareholders of
Israsat International Communications Ltd.

We have audited the financial statements of Israsat International Communications
Ltd. (the Company) as detailed below:

-     Balance sheets as at December 31, 1996, and December 31, 1997.

-     Statements of income, changes in shareholders' equity and cash flows for
      the years ended on December 31, 1995, 1996 and 1997.

The financial statements are the responsibility of the Company's Board of
Directors and of its management. Our responsibility is to express an opinion on
the financial statements based on our audit.

We conducted our audits in accordance with generally accepted auditing
standards, including standards prescribed by the Auditors Regulations (Auditor's
Mode of Performance) - 1973. Such auditing standards are substantially identical
to generally accepted auditing standards in the United States. These standards
require that we plan and perform the audit to obtain reasonable assurance that
the financial statements are free of material misstatement, whether due to error
or intentional misrepresentation.

An audit includes examining, on a test basis, evidence supporting the amounts
(including the reconciliation of the net income and shareholders' equity to U.S.
generally accepted accounting principles) and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by the Board of Directors and management as well as
evaluating the overall financial statements presentation. We believe that our
audits provide a fair basis for our opinion.

The above mentioned financial statements have been prepared on the basis of the
historical cost convention and are expressed in U.S. dollars on the basis
disclosed in Note 1B.
<PAGE>

In our opinion, based upon our audits, the above mentioned financial statements
present fairly, in all material respects, the financial position of the
Company as at December 31, 1996 and 1997, and the changes in shareholders'
equity and the results of their operations and cash flows, for each of the three
years ended on December 31, 1997 in conformity with generally accepted
accounting principles (GAAP) in Israel (as applicable to these financial
statements, Israeli GAAP and U.S. GAAP are substantially identical in all
material respects, except as otherwise described in Note 20 to the financial
statements).


/s/ Somekh Chaikin

Somekh Chaikin
Certified Public Accountants (Isr.)